Clinical Trial Update: Evaluating The Impact Of Donepezil Hydrochloride (Aricept) On Behavioral And Psychological Symptoms In Patients With Severe Alzheimer's Disease [Phase 4]

View source ↗

Summary

The Phase 4 trial evaluating donepezil for behavioral and psychological symptoms in severe Alzheimer's disease was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Aricept (Donepezil)

Snippet

Sponsor: Eisai Inc. | Conditions: Severe Alzheimer's Disease | Phase 4 | Status: WITHDRAWN